Page 53 - Read Online

Friedman et al. Plast Aesthet Res 2023;10:23 https://dx.doi.org/10.20517/2347-9264.2022.100 Page 11 of 15

Provided final approval of the version to be published and agreed to be accountable for all aspects of the
work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately
investigated and resolved: Friedman R, Kinney JR, Bahadur A, Singhal D.

Availability of data and materials
Not applicable.

Financial support and sponsorship
The research reported in this publication was partially supported by the National Heart, Lung, and Blood
Institute of the National Institutes of Health (https://www.nhlbi.nih.gov/) under Award Number
R01HL157991. Rosie Friedman is sponsored by the 2022 JOBST Lymphatic Research Grant awarded by the
Boston Lymphatic Symposium, Inc.

Conflict of Interest
None.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Consent was obtained for the acquisition of intraoperative patient photographs for research purposes.

Copyright
© The Author(s) 2023.

REFERENCES
1. Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG. Breast cancer-related lymphedema: risk factors, precautionary
measures, and treatments. Gland Surg 2018;7:379-403. DOI PubMed PMC
2. Armer JM, Radina ME, Porock D, Culbertson SD. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs
Res 2003;52:370-9. DOI PubMed
3. Fu MR, Rosedale M. Breast cancer survivors' experiences of lymphedema-related symptoms. J Pain Symptom Manage 2009;38:849-
59. DOI PubMed PMC
4. Jørgensen MG, Hermann AP, Madsen AR, et al. Cellulitis is associated with severe breast cancer-related lymphedema: an
observational study of tissue composition. Cancers 2021;13:3584. DOI PubMed PMC
5. Jørgensen MG, Toyserkani NM, Hansen FG, Bygum A, Sørensen JA. The impact of lymphedema on health-related quality of life up
to 10 years after breast cancer treatment. NPJ Breast Cancer 2021;7:70. DOI PubMed PMC
6. Khan F, Amatya B, Pallant JF, Rajapaksa I. Factors associated with long-term functional outcomes and psychological sequelae in
women after breast cancer. Breast 2012;21:314-20. DOI PubMed
7. Boyages J, Xu Y, Kalfa S, et al. Financial cost of lymphedema borne by women with breast cancer. Psychooncology 2017;26:849-55.
DOI PubMed PMC
8. Johnson AR, Asban A, Granoff MD, et al. Is Immediate lymphatic reconstruction cost-effective? Ann Surg 2021;274:e581-8. DOI
9. Shaitelman SF, Cromwell KD, Rasmussen JC, et al. Recent progress in the treatment and prevention of cancer-related lymphedema.
CA Cancer J Clin 2015;65:55-81. DOI PubMed PMC
10. Martínez-Jaimez P, Armora Verdú M, Forero CG, et al. Breast cancer-related lymphoedema: risk factors and prediction model. J Adv
Nurs 2022;78:765-75. DOI
11. Johnson AR, Kimball S, Epstein S, et al. Lymphedema incidence after axillary lymph node dissection: quantifying the impact of
radiation and the lymphatic microsurgical preventive healing approach. Ann Plast Surg 2019;82:S234-41. DOI
12. DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-
analysis. Lancet Oncol 2013;14:500-15. DOI PubMed
13. Hill WKF, Deban M, Platt A, Rojas-Garcia P, Jost E, Temple-Oberle C. Immediate lymphatic reconstruction during axillary node
dissection for breast cancer: a systematic review and meta-analysis. Plast Reconstr Surg Glob Open 2022;10:e4291. DOI PubMed
PMC
14. Pereira ACP, Koifman RJ, Bergmann A. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-